Cargando…
Insufficient Evidence for “Autism-Specific” Genes
Despite evidence that deleterious variants in the same genes are implicated across multiple neurodevelopmental and neuropsychiatric disorders, there has been considerable interest in identifying genes that, when mutated, confer risk that is largely specific for autism spectrum disorder (ASD). Here,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212289/ https://www.ncbi.nlm.nih.gov/pubmed/32359473 http://dx.doi.org/10.1016/j.ajhg.2020.04.004 |
_version_ | 1783531591204601856 |
---|---|
author | Myers, Scott M. Challman, Thomas D. Bernier, Raphael Bourgeron, Thomas Chung, Wendy K. Constantino, John N. Eichler, Evan E. Jacquemont, Sebastien Miller, David T. Mitchell, Kevin J. Zoghbi, Huda Y. Martin, Christa Lese Ledbetter, David H. |
author_facet | Myers, Scott M. Challman, Thomas D. Bernier, Raphael Bourgeron, Thomas Chung, Wendy K. Constantino, John N. Eichler, Evan E. Jacquemont, Sebastien Miller, David T. Mitchell, Kevin J. Zoghbi, Huda Y. Martin, Christa Lese Ledbetter, David H. |
author_sort | Myers, Scott M. |
collection | PubMed |
description | Despite evidence that deleterious variants in the same genes are implicated across multiple neurodevelopmental and neuropsychiatric disorders, there has been considerable interest in identifying genes that, when mutated, confer risk that is largely specific for autism spectrum disorder (ASD). Here, we review the findings and limitations of recent efforts to identify relatively “autism-specific” genes, efforts which focus on rare variants of large effect size that are thought to account for the observed phenotypes. We present a divergent interpretation of published evidence; discuss practical and theoretical issues related to studying the relationships between rare, large-effect deleterious variants and neurodevelopmental phenotypes; and describe potential future directions of this research. We argue that there is currently insufficient evidence to establish meaningful ASD specificity of any genes based on large-effect rare-variant data. |
format | Online Article Text |
id | pubmed-7212289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72122892020-10-09 Insufficient Evidence for “Autism-Specific” Genes Myers, Scott M. Challman, Thomas D. Bernier, Raphael Bourgeron, Thomas Chung, Wendy K. Constantino, John N. Eichler, Evan E. Jacquemont, Sebastien Miller, David T. Mitchell, Kevin J. Zoghbi, Huda Y. Martin, Christa Lese Ledbetter, David H. Am J Hum Genet Commentary Despite evidence that deleterious variants in the same genes are implicated across multiple neurodevelopmental and neuropsychiatric disorders, there has been considerable interest in identifying genes that, when mutated, confer risk that is largely specific for autism spectrum disorder (ASD). Here, we review the findings and limitations of recent efforts to identify relatively “autism-specific” genes, efforts which focus on rare variants of large effect size that are thought to account for the observed phenotypes. We present a divergent interpretation of published evidence; discuss practical and theoretical issues related to studying the relationships between rare, large-effect deleterious variants and neurodevelopmental phenotypes; and describe potential future directions of this research. We argue that there is currently insufficient evidence to establish meaningful ASD specificity of any genes based on large-effect rare-variant data. Elsevier 2020-05-07 2020-04-30 /pmc/articles/PMC7212289/ /pubmed/32359473 http://dx.doi.org/10.1016/j.ajhg.2020.04.004 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Myers, Scott M. Challman, Thomas D. Bernier, Raphael Bourgeron, Thomas Chung, Wendy K. Constantino, John N. Eichler, Evan E. Jacquemont, Sebastien Miller, David T. Mitchell, Kevin J. Zoghbi, Huda Y. Martin, Christa Lese Ledbetter, David H. Insufficient Evidence for “Autism-Specific” Genes |
title | Insufficient Evidence for “Autism-Specific” Genes |
title_full | Insufficient Evidence for “Autism-Specific” Genes |
title_fullStr | Insufficient Evidence for “Autism-Specific” Genes |
title_full_unstemmed | Insufficient Evidence for “Autism-Specific” Genes |
title_short | Insufficient Evidence for “Autism-Specific” Genes |
title_sort | insufficient evidence for “autism-specific” genes |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212289/ https://www.ncbi.nlm.nih.gov/pubmed/32359473 http://dx.doi.org/10.1016/j.ajhg.2020.04.004 |
work_keys_str_mv | AT myersscottm insufficientevidenceforautismspecificgenes AT challmanthomasd insufficientevidenceforautismspecificgenes AT bernierraphael insufficientevidenceforautismspecificgenes AT bourgeronthomas insufficientevidenceforautismspecificgenes AT chungwendyk insufficientevidenceforautismspecificgenes AT constantinojohnn insufficientevidenceforautismspecificgenes AT eichlerevane insufficientevidenceforautismspecificgenes AT jacquemontsebastien insufficientevidenceforautismspecificgenes AT millerdavidt insufficientevidenceforautismspecificgenes AT mitchellkevinj insufficientevidenceforautismspecificgenes AT zoghbihuday insufficientevidenceforautismspecificgenes AT martinchristalese insufficientevidenceforautismspecificgenes AT ledbetterdavidh insufficientevidenceforautismspecificgenes |